Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
DE000A40ZVN7
Thu, 19.03.2026
Viromed Medical AG
Viromed Medical AG: Anna Heinen appointed to the Supervisory Board
Rellingen, March 19, 2026 – Viromed Medical AG (“Viromed”; ISIN: DE000A40ZVN7), a medical technology company and pioneer in cold plasma technology, has appointed a new member to its Supervisory Board. Anna Heinen was appointed to the Supervisory Board by court order. She succeeds [ … ]
Tue, 27.01.2026
Viromed Medical AG
PRESS RELEASE
MHH to Present Scientific Findings on Cold Plasma Therapy for Pulmonary Application at Press Conference in February 2026
Rellingen, 27 January 2026 – On 12 February 2026, Hannover Medical School (MHH) – represented by Prof. Dr. Hortense Slevogt – plans to hold a press conference together with the team from the Helmholtz Centre for I [ … ]
Mon, 19.01.2026
Viromed Medical AG
PRESS RELEASE
Viromed Medical AG: Ex-vivo lung study marks milestone for research and approval
Rellingen, 19 January 2026 – Viromed Medical AG (“Viromed”; ISIN: DE000A40ZVN7), a medical technology company and pioneer in cold plasma technology, will conduct the announced ex-vivo study on vital lungs in cooperation with Saarland University and Hann [ … ]
